B. Dambaya

发表

First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens

V. Colizzi, C. Perno, S. Billong, 2020, Antimicrobial Resistance & Infection Control.

HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: a systematic review and meta-analysis protocol

A. Wiyeh, F. Ceccherini‐Silberstein, V. Colizzi, 2020, Systematic Reviews.

HIV-1 Gag gene mutations, treatment response and drug resistance to protease inhibitors: A systematic review and meta-analysis protocol

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2021, PloS one.

Implementation of HIV early infant diagnosis and HIV type 1 RNA viral load determination on dried blood spots in Cameroon: challenges and propositions.

V. Colizzi, A. Bissek, O. Ouwe-Missi-Oukem-Boyer, 2012, AIDS research and human retroviruses.

Maternal age, infant age, feeding options, single/multiple pregnancy, type of twin sets and mother-to-child transmission of HIV.

J. Thèze, V. Colizzi, A. Bissek, 2018, Journal of tropical pediatrics.

IMPLICATION OF FIVE AIDS RELATED GENES IN MOTHER-TO-CHILD TRANSMISSION AND ACQUISITION OF HUMAN IMMUNODEFICIENCY VIRUS 1 IN CAMEROON

J. Kuiaté, C. Nkenfou, A. Ndjolo, 2018, African journal of infectious diseases.

Immunoglobulin G Specific Antibody Level against Ebola Viral Glycoprotein and Nucleoprotein in Ebola Virus Disease Survivors and Their Relatives

C. Montesano, A. Minutolo, M. Giovanetti, 2021, Journal of Biosciences and Medicines.

HIV-1 Gag gene mutations, treatment response and drug resistance to protease inhibitors: A systematic review and meta-analysis protocol

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2020, PloS one.

HLA A*32 is associated to HIV acquisition while B*44 and B*53 are associated with protection against HIV acquisition in perinatally exposed infants

J. Kuiaté, C. Nkenfou, A. Ndjolo, 2019, BMC Pediatrics.

CCR2 polymorphism and HIV: mutation in both mother and child is associated with higher transmission.

Georges Nguefack-Tsague, S. Billong, W. Mbacham, 2019, International journal of biochemistry and molecular biology.

Host Molecular Factors and Viral Genotypes in the Mother-to-Child HIV-1 Transmission in Sub-Saharan Africa

C. Nkenfou, B. Dambaya, L. C. M. Mouafo, 2017, Journal of public health in Africa.

Archiving of mutations in HIV‐1 cellular reservoirs among vertically infected adolescents is contingent with clinical stages and plasma viral load: Evidence from the EDCTP‐READY study

V. Colizzi, C. Perno, M. Santoro, 2021, HIV medicine.

Differential of Antioxidant Ability, CD4+T Cells Count and Viral Load in HIV Infected Patients on cART in Yaounde, Cameroon

J. Fokam, A. Ndjolo, D. Takou, 2020 .

Viral Hepatitis B and C Detection among Ebola Survivors and Health Care Workers in Makeni, Sierra Leone

C. Montesano, A. Minutolo, M. Giovanetti, 2020, Journal of Biosciences and Medicines.

HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: A systematic review and meta-analysis

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2022, PLOS Global Public Health.

Alarming rates of virological failure and HIV‐1 drug resistance amongst adolescents living with perinatal HIV in both urban and rural settings: evidence from the EDCTP READY‐study in Cameroon

F. Ceccherini‐Silberstein, C. Perno, V. Colizzi, 2021, HIV medicine.

TRIM5α 136Q, CCR5 Promoter 59029G And CCR264I Alleles Impact The Progression Of HIV In Children And Adolescents

V. Colizzi, C. Nkenfou, L. Mekue, 2019, The application of clinical genetics.

Characterization of Asymptomatic Children Infected with the Human Immunodeficiency Virus at Birth

J. Thèze, V. Colizzi, C. Nkenfou, 2015 .

Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2022, Viruses.

Evaluation of Circulating and Archived HIV-1 Integrase Drug-Resistance Variants among Patients on Third-Line ART in Cameroon: Implications for Dolutegravir-Containing Regimens in Resource-Limited Settings

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2022, Microbiology spectrum.

High performance of integrase genotyping on diverse HIV-1 clades circulating in Cameroon: toward a successful transition to dolutegravir-based regimens in low and middle-income countries.

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2021, Diagnostic microbiology and infectious disease.

Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings.

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2021, The Journal of antimicrobial chemotherapy.

HIV-1 Drug Resistance and Genetic Diversity among Vertically Infected Cameroonian Children and Adolescents

V. Colizzi, F. Njiokou, C. Perno, 2020, Exploratory Research and Hypothesis in Medicine.

HIV-1 Drug Resistance and Genetic Diversity among Vertically Infected Cameroonian Children

J. Fokam, B. Dambaya, E. Ngoufack, 2019 .

HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon

F. Ceccherini‐Silberstein, V. Colizzi, C. Fokunang, 2019, BMC Infectious Diseases.

Human Leucocyte Antigen Class I Diversity among Human Immunodeficiency Virus Exposed Negative and Positive Children in Cameroon.

C. Montesano, M. Amicosante, A. Grifoni, 2015 .

Detection of Gag C-terminal mutations among HIV-1 non-B subtypes in a subset of Cameroonian patients

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2022, Scientific Reports.

Evaluation of HIV-1 capsid genetic variability and lenacapavir (GS-6207) drug resistance-associated mutations according to viral clades among drug-naive individuals.

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2022, The Journal of antimicrobial chemotherapy.

Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line Regimens

F. Ceccherini‐Silberstein, V. Colizzi, C. Fokunang, 2023, Viruses.

Laboratory Based Surveillance of HIV-1 Acquired Drug Resistance in Cameroon: Implications for Use of Tenofovir-Lamivudine-Dolutegravir (TLD) as Second- or Third-Line Regimens

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2023, Viruses.

HIV-1 subtype diversity and immuno-virological outcomes among adolescents failing antiretroviral therapy in Cameroon: A cohort study

V. Colizzi, C. Perno, M. Santoro, 2023, PloS one.